The BRICS Times is a dynamic online news portal headquartered in Khamgaon, India, dedicated to delivering timely and insightful news from the BRICS nations and around the globe. With a focus on business, politics, technology, and culture, The BRICS Times strives to provide readers with accurate, engaging, and up-to-date content. Committed to journalistic integrity and a reader-first approach, the portal serves as a reliable source for anyone seeking a deeper understanding of the economic and social developments shaping the BRICS countries.
The BRICS TimesThailand’s Foreign Minister requests New Delhi’s backing for full BRICS membership during India’s 2026 presidency. Bilateral talks held with EAM S Jaishankar in New Delhi focused on geopolitical shifts and…
The BRICS TimesPalestine has officially applied to join BRICS. China has shown a supportive stance on Palestine’s membership. The Chinese Foreign Ministry stated, “We welcome more like-minded countries into BRICS.” In a…
The BRICS TimesIn his address to the virtual Brics Summit, Jaishankar said it was imperative that economic practices were fair, transparent and to everyone’s benefit. India on Monday urged the Brics forum…
The BRICS TimesJaishankar stated that the world needs to have a “constructive and cooperative” approach towards trade. During the BRICS summit held virtually on Monday, External Affairs Minister S Jaishankar emphasized that…
The BRICS TimesIndia and Brazil are working together to counter U.S. President Donald Trump’s tariff measures. New Delhi may soon hold talks with the Brazil-led Latin American trade bloc to explore possibilities…
The BRICS TimesAs confirmed by the Head of the Laotian Government, the possibility is now under thorough consideration Prime Minister of Laos, Sonexay Siphandone, has voiced his nation’s aspiration to join the…
The BRICS TimesThe medicine marks the nation’s first homegrown EZH2 inhibitor Jiangsu Hengrui Pharmaceuticals announced on Monday that the National Medical Products Administration has granted conditional authorization for its latest oncology treatment,…
The BRICS Times
